Marginatoxin, with the CAS number 1422536-56-8, is a chemical compound that has garnered attention due to its biological activity. It is classified as a cyclic peptide and is known for its potential pharmacological properties, particularly in the context of its effects on cellular processes. Marginatoxin is derived from marine organisms, specifically certain species of marine bacteria, which contributes to its unique structural characteristics and bioactivity. The compound exhibits a range of biological activities, including potential antimicrobial and cytotoxic effects, making it a subject of interest in medicinal chemistry and drug development. Its structure typically features a series of amino acids arranged in a cyclic formation, which is crucial for its interaction with biological targets. Research into marginatoxin is ongoing, focusing on elucidating its mechanisms of action and potential therapeutic applications. As with many natural products, understanding its properties and effects can lead to insights into new drug discovery and development pathways.

Marginatoxin

1422536-56-8: Marginatoxin, with the CAS number 1422536-56-8, is a chemical compound that has garnered attention due to its biological activity. It is classified as a cyclic peptide and is known for its potential pharmacological properties, particularly in the context of its effects on cellular processes. Marginatoxin is derived from marine organisms, specifically certain species of marine bacteria, which contributes to its unique structural characteristics and bioactivity. The compound exhibits a range of biological activities, including potential antimicrobial and cytotoxic effects, making it a subject of interest in medicinal chemistry and drug development. Its structure typically features a series of amino acids arranged in a cyclic formation, which is crucial for its interaction with biological targets. Research into marginatoxin is ongoing, focusing on elucidating its mechanisms of action and potential therapeutic applications. As with many natural products, understanding its properties and effects can lead to insights into new drug discovery and development pathways.

Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in

Marginatoxin is a highly specialized toxin derived from marine invertebrates. It is sourced from certain species of sea anemones, where it naturally occurs as part of the organism's chemical defense mechanisms. The mode of action of Marginatoxin involves the selective modulation of ion channels, particularly affecting sodium and potassium channels in excitable cells.

CAS 1422536-56-8

Marginatoxin

Marginatoxin

Ref: TM-TN4496

Marginatoxin

Ref: 3D-XGC53656